Mesoblast | MSB - Net Income

Stock Price
2.14
Daily Change
-0.05 -2.28%
Monthly
0%
Yearly
19.55%
Q2 Forecast
2.15

Mesoblast reported $-40.16M in Net Income for its fiscal semester ending in December of 2025.





Net Income Change Date
Avita Medical AUD -11.62M 1.7M Dec/2025
Clinuvel Pharmaceuticals AUD 10.44M 11.65M Dec/2025
Cochlear AUD 161.5M 69.6M Dec/2025
CSL USD 401M 96.5M Dec/2025
Pacific Edge NZD -19.12M 3.68M Dec/2025
Paradigm Biopharmaceuticals AUD -23.24M 16.82M Dec/2025
PYC Therapeutics AUD -22.83M 10.46M Dec/2025
Ramsay Health Care AUD 152.7M 32.4M Dec/2025
Sonic Healthcare AUD 236.68M 82.29M Dec/2024
Starpharma Holdings AUD 1.37M 3.67M Dec/2025
Telix Pharmaceuticals AUD -4.83M 2.54M Dec/2025